ReviewFrontiers in endocrinology2026
Peppermint oil in menstrual disorders and menopausal symptoms: a research progress review.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally, approximately 80-95% of women of reproductive age are affected by premenstrual syndrome and menstrual-related symptoms, which significantly impair their quality of life. Although non-steroidal anti-inflammatory drugs and hormonal therapies are considered first-line treatment options, they are limited by adverse effects and restrictions on applicable populations. Peppermint oil is a natural plant extract. Its primary bioactive component, menthol, exhibits significant antioxidant, anti-inflammatory, and smooth muscle relaxant pharmacological activities. It has shown preliminary application potential in the management of menstrual disorders and menopausal symptoms, yet it is still in the early stage of research. This review synthesizes current research progress on peppermint oil in the management of menstrual disorders and menopausal symptoms, with a focus on its pharmacological basis, clinical application evidence, and existing controversies and research gaps. Available evidence indicates that peppermint oil exerts preliminary efficacy in alleviating primary dysmenorrhea and improving genitourinary symptoms of menopause. These effects are mediated by multi-target mechanisms, including ion channel modulation, inhibition of inflammatory pathways, and regulation of the neuroendocrine network. However, current research faces key bottlenecks, including fragmented clinical evidence, unclear mechanisms of action, lack of product quality standardization, and insufficient long-term safety data. To address these challenges, future efforts should prioritize large-scale, standardized randomized controlled trials. In parallel, future research may also integrate multi-omics technologies to elucidate its molecular mechanisms and develop novel drug delivery systems to enhance bioavailability. We hypothesize that this pathway holds promise for moving peppermint oil from traditional experience toward evidence-based medicine, though the precision medicine framework remains an exploratory direction given the current state of evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.